Note 13 - Subsequent Events |
6 Months Ended |
|---|---|
Jun. 30, 2026 | |
| Notes to Financial Statements | |
| Subsequent Events [Text Block] |
Stockholder Cooperation Agreement
On July 1, 2026, the Company entered into a cooperation agreement with a stockholder group. Pursuant to the agreement, the stockholder group withdrew its notice nominating three director candidates for election at the Company’s 2026 Annual Meeting of Stockholders and withdrew its demand to inspect certain books and records of the Company. The agreement provides for, among other matters, the appointment of a mutually agreed-upon independent director, the formation of a Clinical and Regulatory Affairs Committee and a Stockholder Engagement Committee, and the adoption of director stock ownership guidelines and a resignation policy. The Company agreed to reimburse the stockholder group for reasonable and documented out-of-pocket expenses, subject to a cap of $650,000.
|